The effect of anterograde or retrograde iodine staining on the integrity and safety of esophageal iodine staining

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200065851

Enrollment

Unknown

Registered

2022-11-16

Start date

2022-11-20

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal early cancer and Iodine staining

Interventions

Retrograde iodine staining group:Retrograde iodine staining

Anterograde iodine staining group:Anterograde iodine staining

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients aged >= 18 years; 2. Patients need to perform gastroduodenoscopy and iodine staining; 3. Patients who signed informed consent; 4. Patients under general anesthesia.

Exclusion criteria

Exclusion criteria: 1. History of iodine allergy or organ failure; 2. History of acid reflux, heartburn,retrosternal discomfort, or diagnosed with reflux esophagitis; 3. Patients with head and neck cancer under radiotherapy or chemotherapy, or diagnosed with esophageal varices, advanced esophageal cancer; 4. Pregnant women or breast-feeding women; 5. Patients with high risk of anesthesia.

Design outcomes

Primary

Measure	Time frame
Iodine reflux rate;	—

Secondary

Measure	Time frame
Effects of iodine staining;	—

Countries

China

Contacts

Public ContactKai Deng

Department of Gastroenterology, West China Hospital, Sichuan University

dengkai11111@qq.com+86 18224451156

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026